Table 2.
Ref. | Spike |
Extraction |
Analytical |
Whole-method LOD (µg/L) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
nC60 type | nC60 conc. (mg/L) | Matrix |
Concentration factor |
Injection Volume (μL) | Detection | λ (nm) or Ions (m/z) | |||||
LLE | SPE | Evap./Filtr. | |||||||||
[76] | PVP/C60 | 10 000 | Plasma | 0.05 | - | - | 5 | UV-Vis | - | 256 nm (hex) | 500b |
SAA | SAA | SAA | SAA | - | - | 10 | - | APCI-MS | TIC, m/z 720 | 5 000b | |
[32] | tol/nC60 | 50–200 000 | Blood | 0.03–0.3 | - | - | 50 | UV-Vis | APCI-MS | 333 nm, m/z 150–1 000 | NRg |
SAA | NAe | Liver | NAe | - | - | SAA | UV-Vis | SAA | SAA | SAA | |
SAA | NAe | Spleen | NAe | - | - | SAA | UV-Vis | SAA | SAA | SAA | |
[37] | THF/nC60 | 3.1 | 4.5% BSA | 10 | - | NR | UV-Vis | - | 333 nm | 0.34 | |
SAA | SAA | 50% plasma | SAA | - | - | SAA | SAA | - | SAA | 0.68 | |
tol/C60 | 40 μg | Skin | NR | - | - | SAA | SAA | - | SAA | NR | |
[60] | DMSO/nC60 | 100–400 | Fish embryos | 1 | - | - | 500 | - | ESI-MS | m/z 720, 728–740, 736 | 0.02c |
SAA | SAA | 1% DMSO | 1 | - | SAA | - | SAA | SAA | |||
[41] | aqu/nC60 | 63.4–8 770 | GW/SW | 0.5 | - | - | 100 | UV-Vis | - | 333 nm | 2.48 |
SAA | SAA | SAA | 20 | - | - | SAA | SAA | - | SAA | 0.746 | |
SAA | SAA | SAA | - | 12 | - | SAA | SAA | - | SAA | 0.746 | |
[64] | tol/nC60 | 0.5–5 | UPW | - | - | 111 | NR | - | APCI-MS | TIC, m/z 720, 1 440, 360 | 2.8 |
SAA | 10–25 | Tap water | 55.6 | - | - | SAA | - | SAA | SAA | 3.3 | |
SAA | NR | SAA | - | 1000 | - | SAA | - | SAA | SAA | 0.30 | |
[39] | Bulk C60 | NAf | Tissue | NAe | - | - | 5 | UV-Vis | - | 330 | NR |
SAA | Lung | SAA | SAA | - | SAA | SAA | - | SAA | SAA | ||
SAA | Blood | SAA | SAA | - | SAA | SAA | - | SAA | SAA | ||
[43] | tol/nC60 | 5 000 | UPW | 1 | - | - | 100 | UV-Vis | - | NR | 250d |
SAA | SAA | 5 mg/L-C NOM | 1 | - | - | SAA | SAA | - | SAA | NRd | |
SAA | SAA | 50 mg/L-C NOM | 1 | - | - | SAA | SAA | - | SAA | NRd | |
SAA | SAA | 1 % SDS | 1 | - | - | SAA | SAA | - | SAA | NRd | |
[14] | NA | 0.5–1.5 | WWTP effluent | - | - | 133 | 150 | - | ESI-MS | m/z 720, 736, 840, 856 | 0.005 |
[65] | tol/nC60 | 20–200 | UPW, WWa | 10 | - | - | 100 | UV-Vis | - | 332 nm | 3–4 |
SAA | SAA | SAA | SAA | - | - | SAA | - | APCI-MS | m/z 720 | 4–11 | |
SAA | 1–4 | Recl. WW | - | 1000 | - | SAA | UV-Vis | - | 332 nm | 0.42 | |
SAA | SAA | Sec. effluent | - | SAA | - | SAA | SAA | - | SAA | 0.64 |
APCI, atmospheric pressure chemical ionization; BSA, bovine serum albumin; Conc., concentration; DMSO, dimethyl sulfoxide; ESI, electrospray ionization; Evap., evaporation; Filtr., filtration; GW, groundwater; hex, hexane; LOD, limit of detection; MS, mass spectrometry; NA, not applicable; NOM, natural organic matter; NR, information is not reported; PVP, polyvinylpyrrolidone; Rec., reclaimed; SAA, same as above; SDS, sodium dodecyl sulfate; Sec. effluent, secondary effluent; SW, surface water; THF, tetrahydrofuran; TIC, total ion count; tol, toluene; UPW, ultrapure water; WW, wastewater; WWTP, wastewater treatment plant.
five different wastewater matrices;
instrument detection limit, 0.05 ng at S, N=2;
Detection limit, 0.0002 ng and quantification limit, 0.001 ng;
Methodology for whole-method LOD determination is not reported;
After inhalation and distribution among the organs via blood circulation;
2.22 mg/m3 C60 at an inhalation rate of 140 mL/min;
instrument detection limit = 0.1 ng of C60 injected